AMRZ Form 4: Michael McKelvy receives 2,958 restricted stock units
Rhea-AI Filing Summary
Amrize Ltd (AMRZ) reported a restricted stock unit award to director Michael E. McKelvy consisting of 2,958 ordinary shares granted under the Amrize Ltd 2025 Omnibus Incentive Plan. The grant is recorded as having a $0 price because it is a restricted stock unit award, and the reporting person is shown as the direct beneficial owner of 2,958 shares following the award.
The award vests on the earlier of the one-year anniversary of the grant date or the company’s next regular annual meeting of shareholders, which means the shares are subject to time-based vesting conditions before becoming transferable.
Positive
- 2,958 RSUs awarded to Director Michael E. McKelvy under the Amrize Ltd 2025 Omnibus Incentive Plan, aligning director and shareholder interests
- Clear vesting schedule: award vests on the earlier of one year or the issuer's next regular annual meeting, establishing explicit service conditions
Negative
- None.
Insights
TL;DR: Director received 2,958 RSUs, vesting within one year or at the next annual meeting; a standard equity retention award.
The Form 4 discloses a non‑derivative award of 2,958 restricted stock units to director Michael E. McKelvy under the 2025 Omnibus Incentive Plan. The award is recorded with a $0 price consistent with RSU grants and is shown as directly beneficially owned following the grant. The vesting condition—earlier of one year or the next regular annual meeting—ties the award to continued service through a definable short-term period. This is a routine governance action to align a director’s interests with shareholders without indicating litigation, financing, or operational changes.
TL;DR: Typical board compensation event: time‑based RSU award to a director with clear vesting terms.
Documentation shows a restricted stock unit grant under the company’s 2025 Omnibus Incentive Plan to Director Michael E. McKelvy, with vesting tied to service for up to one year or the next annual meeting. The Form 4 records direct beneficial ownership of 2,958 shares post‑grant. From a governance perspective, this type of award is a common mechanism to align director incentives to shareholder outcomes while retaining executive oversight through vesting conditions.